Advertisement
Advertisement

NVNO

NVNO logo

enVVeno Medical Corporation Common Stock

11.29
USD
Sponsored
-0.64
-5.36%
Feb 02, 15:59 UTC -5
Closed
exchange

After-Market

11.24

-0.04
-0.40%

NVNO Earnings Reports

Positive Surprise Ratio

NVNO beat 13 of 23 last estimates.

57%

Next Report

Date of Next Report
Feb 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.28
Implied change from Q3 25 (Revenue/ EPS)
--
/
-96.52%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-6.67%

enVVeno Medical Corporation Common Stock earnings per share and revenue

On Nov 03, 2025, NVNO reported earnings of -8.05 USD per share (EPS) for Q3 25, beating the estimate of -10.71 USD, resulting in a 24.84% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.68% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an decrease of -96.52% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
logo
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.09%
logo
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
For Q3 2025, enVVeno Medical Corporation Common Stock reported EPS of -$8.05, beating estimates by 24.84%, and revenue of $0.00, 0% as expectations.
The stock price moved up 0.68%, changed from $0.70 before the earnings release to $0.71 the day after.
The next earning report is scheduled for Feb 26, 2026.
Based on 3 analysts, enVVeno Medical Corporation Common Stock is expected to report EPS of -$0.28 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement